Hallway Conversations is a series of audio podcasts with thought leaders and newsmakers in the field of epilepsy on a range of seizure related topics. The series covers a range of topics and are intended to address a wide range of audiences.

We hope that you find the series informative and helpful and that you join us in listening on a regular basis.

 Dr. Joseph Sirven, Editor-in-Chief

Inflammatory Causes of Epilepsy

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in Chief of Epilepsy.com/Professionals, interviews Michael R. Sperling, M.D. , Baldwin Keyes Professor of Neurology and Director, Jefferson Comprehensive Epilepsy Center, about Inflammatory Causes of Epilepsy.

Interview With Mr. Warren Lammert, co-founder of the Epilepsy Therapy Project

Samantha Macher (blogger for Epilepsy.com) interviews Mr. Warren Lammert, the co-founder of the Epilepsy Therapy Project. We will be discussing his involvement in the organization, new treatments he finds exciting in 2010, and the new Seizure Diary "apps" for iPod, iPhone and Android phones.

New Classification system of Seizures and Epilepsy

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in Chief of Epilepsy.com/Professionals, interviews Anne T. Berg Ph.D., Professor in the Epilepsy Center, Northwestern Children's Memorial Hospital, Chicago, Illinois, about a New Classification system of Seizures and Epilepsy.

Interview With Dr. Joseph Sirven, Editor-In-Chief of epilepsy.com

Samantha Macher, blogger for epilepsy.com, interviews Joseph Sirven, MD about his work in the field of epileptology and his new role as Editor-in-Chief of epilepsy.com.

Anti seizure Medications: Your Questions answered

Joseph Sirven, MD (editor-in-chief, Epilepsy.com) and Patty Shafer, RN, MSN, (Contributing Editor, epilepsy.com; Resource Specialist, my.epilepsy.com) co-hosted a special Hallway Conversations on Antiseizure Medications where they took calls from the audience.

Pages